KNAUER and 3B Pharmaceuticals showcase novel affinity purification process for camelid antibodies 8. November 2016/in 2016/by imkenKNAUER and 3B Pharmaceuticals showcase novel affinity purification process for camelid antibodies
Ipsen enters into a licensing agreement with 3B Pharmaceuticals to develop novel radiopharmaceuticals in oncology 17. February 2016/in 2016/by imkenIpsen enters into a licensing agreement with 3B Pharmaceuticals to develop novel radiopharmaceuticals in oncology